Reuters logo
BRIEF-Glenmark Pharmaceuticals and Evestra sign partnership agreement for generic nuvaring
March 2, 2017 / 3:56 AM / 7 months ago

BRIEF-Glenmark Pharmaceuticals and Evestra sign partnership agreement for generic nuvaring

March 2 (Reuters) - Glenmark Pharmaceuticals Ltd

* Says Glenmark Pharmaceuticals and Evestra, Inc. announce partnership agreement for generic nuvaring

* Development on vaginal ring product under way ; cos expect to file an abbreviated new drug application (ANDA) in fiscal 2019

* Says secured exclusive marketing, distribution rights for product

* Says co has option to commercialize two additional evestra vaginal ring products, for the U.S. Market

* Evestra will develop product exclusively for glenmark for U.S. market; will get some milestone payments during various stages of development Source text - (bit.ly/2mNpcJX) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below